BDNF Cancer Research Results
BDNF, brain-derived neurotrophic factor: Click to Expand ⟱
| Source: |
| Type: |
Brain-Derived Neurotrophic Factor (BDNF) is a key neurotrophin (a type of growth factor) involved in brain health, and its role in Alzheimer’s Disease (AD) has been extensively studied.
-AD patients often have lower BDNF levels in key brain regions, such as the hippocampus and cortex.
-This reduction correlates with cognitive decline and brain atrophy.
-BDNF normally protects neurons from Aβ toxicity
-Exercise and cognitive training have been shown to boost BDNF levels and may slow cognitive decline.
- natural compounds (like curcumin or flavonoids) may also upregulate BDNF.
|
Stroke, Cerebral Ischemic Stroke: Click to Expand ⟱
Ischemic stroke is also called brain ischemia and cerebral ischemia. Ischemia is the medical term for "lack of blood supply."
|
Scientific Papers found: Click to Expand⟱
*BDNF↑, *neuroP↑, *TrkB↑, *PI3K↑, *Akt↑, *MAPK↑, *ERK↑, *NO↓, *MDA↓, *SOD↑, *TNF-α↓, *IL1β↓, *IL6?,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
cardioP↑, Inflam↓, cognitive↑, *hepatoP↑, *ROS?, *SOD↑, *GSH↑, *MMP↑, *GutMicro↑, ChemoSen↑, *TNF-α↓, *IL10↑, *IL6↓, *eff↑, *ROS↓, *COX2↓, *NF-kB↓, *STAT3↓, *PGE2↓, *MPO↓, *IL1β↓, *MMP2↓, *MMP9↓, *β-Amyloid↓, *neuroP↑, *Dose↝, *BioAv↝, *BioAv↝, *BBB↑, *BDNF↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *AChE↓, *BBB↑, *cardioP↑, *neuroP↑, *memory↑, *TAC↑, *ROS↓, *lipid-P↓, *MDA↓, *SOD↑, *Catalase↑, *NRF2↑, *cognitive↑, *IL1β↓, *COX2↓, *TNF-α↓, *TLR4↓, *BDNF↑, *PKCδ↑, *5LO↓, *TRPM7↓, *GSH↑, *other↑, *Ferroptosis↓, *GPx4↑,
*BDNF↑, *homoC↓,
*MDA↓, *IL6↓, *SOD↑, *BDNF↑, *ROS↓, *Inflam↓, *neuroP↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *ROS↓, *neuroP↑, *NO↑, BioAv↝, *BBB↑, *toxicity↑, *eff↑, *GSH↑, *SOD↑, *Aβ↓, *12LOX↓, *COX2↓, *Catalase↑, *Inflam↓, *TNF-α↓, *IL6↑, *lipid-P↓, NF-kB↓, IL1β↓, NRF2↑, HO-1↑, GSTs↑, cognitive↑, *BDNF↑,
| - |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*BDNF↑, *TrkB↑, *neuroP↑, *VEGF↑, *p‑tau↓, *memory↑,
*neuroP↑, *Inflam↓, *antiOx↑, *BDNF↑, *Casp3↓,
*Apoptosis↓, *cognitive↑, *BDNF↑, *TrkB↑, *CREB↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
MS, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *neuroP↑, *BioAv↝, *BBB↑, *TNF-α↓, *IL1β↓, *IL6↓, *IL8↓, *IL33↓, *NF-kB↓, *BACE↓, *ROS↓, *SOD↑, *HO-1↑, *NRF2↑, *Casp3↓, *Casp9↑, *Bax:Bcl2↓, *UPR↑, *GRP78/BiP↑, *Aβ↓, *GSK‐3β↓, *tau↓, *CREB↑, *ATP↑, *cognitive↑, *BloodF↑, *BDNF↑, *TrkB↑, *memory↑, *PPARγ↑, *eff↑,
*neuroP↑, *BDNF↑, *Dose↝,
*neuroG↑, *BDNF↑, *motorD↑,
*neuroP↑, *BDNF↑, *TrkB↑, *p‑Akt↑,
*OS↑, *BDNF↑, *IGF-1↑,
| - |
in-vivo, |
Nor, |
NA |
|
|
|
- |
NA, |
Stroke, |
NA |
|
|
|
*neuroP↑, *p‑PTEN↓, *p‑Akt↑, *Bcl-2↑, *BAX↓, *cognitive↑, *BDNF↑,
Showing Research Papers: 1 to 15 of 15
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 15
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GSTs↑, 1, HO-1↑, 1, NRF2↑, 1,
Immune & Inflammatory Signaling ⓘ
IL1β↓, 1, Inflam↓, 1, NF-kB↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↝, 1, ChemoSen↑, 1,
Functional Outcomes ⓘ
cardioP↑, 1, cognitive↑, 2,
Total Targets: 10
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 4, Catalase↑, 2, Ferroptosis↓, 1, GPx4↑, 1, GSH↑, 3, HO-1↑, 1, lipid-P↓, 2, MDA↓, 3, MPO↓, 1, NRF2↑, 2, ROS?, 1, ROS↓, 5, SOD↑, 6, TAC↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↑, 1, MMP↑, 1,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, CREB↑, 2, homoC↓, 1, PPARγ↑, 1,
Cell Death ⓘ
Akt↑, 1, p‑Akt↑, 2, Apoptosis↓, 1, BAX↓, 1, Bax:Bcl2↓, 1, Bcl-2↑, 1, Casp3↓, 2, Casp9↑, 1, Ferroptosis↓, 1, MAPK↑, 1,
Transcription & Epigenetics ⓘ
other↑, 1,
Protein Folding & ER Stress ⓘ
GRP78/BiP↑, 1, UPR↑, 1,
Proliferation, Differentiation & Cell State ⓘ
ERK↑, 1, GSK‐3β↓, 1, IGF-1↑, 1, neuroG↑, 1, PI3K↑, 1, p‑PTEN↓, 1, STAT3↓, 1, TRPM7↓, 1,
Migration ⓘ
5LO↓, 1, MMP2↓, 1, MMP9↓, 1, PKCδ↑, 1,
Angiogenesis & Vasculature ⓘ
NO↓, 1, NO↑, 1, VEGF↑, 1,
Barriers & Transport ⓘ
BBB↑, 4,
Immune & Inflammatory Signaling ⓘ
COX2↓, 3, IL10↑, 1, IL1β↓, 4, IL33↓, 1, IL6?, 1, IL6↓, 3, IL6↑, 1, IL8↓, 1, Inflam↓, 5, NF-kB↓, 2, PGE2↓, 1, TLR4↓, 1, TNF-α↓, 5,
Synaptic & Neurotransmission ⓘ
AChE↓, 1, BDNF↑, 15, tau↓, 1, p‑tau↓, 1, TrkB↑, 5,
Protein Aggregation ⓘ
Aβ↓, 2, BACE↓, 1, β-Amyloid↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↝, 3, Dose↝, 2, eff↑, 3,
Clinical Biomarkers ⓘ
BloodF↑, 1, GutMicro↑, 1, IL6?, 1, IL6↓, 3, IL6↑, 1,
Functional Outcomes ⓘ
cardioP↑, 1, cognitive↑, 4, hepatoP↑, 1, memory↑, 3, motorD↑, 1, neuroP↑, 11, OS↑, 1, toxicity↑, 1,
Total Targets: 86
Scientific Paper Hit Count for: BDNF, brain-derived neurotrophic factor
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:36 Cells:% prod#:% Target#:1356 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page